A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is
Molecular and Conventional based formulations of allergens against allergies
The present review highlights some of the details regarding the use of different allergy-specific immunotherapy (ASIT) to increase the immunogenicity and decrease allergic reactions against a particular protein or peptide used in this ASIT for better treatment or prevention against some well-known allergies, such as allergic rhinitis, asthma, and atopic dermatitis. In this form, DNA based vaccines can also be used to produce high immunogenicity but in a different mechanism. The use ofdoi:10.5281/zenodo.6371073 fatcat:6hrtym6lzbehjgnuo67suecoyi